

Review of master & monthly stability study schedule.Prepare stability study samples using a similar container closure system as used for marketing the Drug Products.Submit the stability study samples to the Quality Control.Issue the stability study test request form to the Quality Control Department.To train the concern persons before the implementation of SOP.Inform any significant change and stability study failure results to QC Head or Designee along with Quality Head.Establish an easy retrieval and secure archiving procedure of stability study documents.Initiate an investigation in case of Out Of Specification (OOS) result/stability study failures.Review the Stability Study Summary Report, Discontinuation, Trend & Evaluation of stability study performed.


#Ich guidance update

Prepare the master and monthly stability study schedule as per the stability study protocol.To maintain the reconciliation of charged stability samples at every stability study station.Receive stability Study Protocol, incubation and withdrawal of samples, samples analysis, reporting of the result, destruction, and discontinuation of stability study samples.Preparation of the stability study protocol.Inform to Head QC or Designee in case of Out of trend and OOS results.Analyze the stability study samples as per SOP.Store all the stability study results along with the associated documents with a sample test form, chromatogram, and other relevant documents.Maintain the analysis schedule and other stability study-related documents.Extension Form For Stability Sample Analysis (Annexure – 11)ģ.0 Responsi bilities as per SOP for Stability Study:.Stability Sample Reconciliation and Destruction Form.Placebo Preparation Record (Annexure – 8).Stability Sample Quantity Format (Annexure – 7).Monthly Schedule for Stability (Annexure – 6).Stability Discontinuation Authorization Form (Annexure – 4).Summary (Stability) Report (Annexure – 3).Master Stability Schedule (Annexure – 2).Stability Analysis Schedule and Cycle (Annexure – 1).Asian Guideline on the stability study of the drug product.This amendment now enters into the implementation period (Step 5).3.0 Reference, Attachments, and Annexures :
#Ich guidance trial
The current amendment (ICH E6(R2)) aims to encourage sponsors to implement improved oversight and management of clinical trials, while continuing to ensure protection of human subjects participating in trials and clinical trial data integrity. The 1996 ICH Guideline on GCP is one of the most significant achievements of the ICH process, establishing harmonised standards for clinical trials. The Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice (GCP) reached Step 4 of the ICH Process in November 2016. The links below provide important information and guidelines on best clinical research practices:Į6: Good Clinical Practice: Consolidated Guideline
